Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2008
11/19/2008CN101306201A Antihypertensive medicine carrier and combination medicine
11/19/2008CN101306197A Administration system of plasminogen activator sustained and controlled release preparation, construction and use thereof
11/19/2008CN101306191A Use of TLR2 ligand PGN in treating metabolism syndrome
11/19/2008CN101306184A Common turmeric extract vein emulsion injection and its preparation method and use
11/19/2008CN101306183A Common turmeric extract fat emulsion injection and its preparation method and use
11/19/2008CN101306181A Elemene fat emulsion injection and preparation method thereof
11/19/2008CN101306169A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease
11/19/2008CN101306167A Antihypertensive traditional Chinese medicine and preparation method thereof
11/19/2008CN101306158A Use of traditional Chinese medicine in preparing medicine for treating myocardial infarction
11/19/2008CN101306156A Yixinfumai capsule
11/19/2008CN101306138A Chinese traditional injection preparation for treating chest stuffiness and pains and its preparation method
11/19/2008CN101306129A Chinese herbal medicine compound preparation for treating hypertension and its preparation method
11/19/2008CN101306116A Xinnaoqingyu decoction
11/19/2008CN101306112A Baimaiyutong paster
11/19/2008CN101306081A Xinshuning tablets quality control method
11/19/2008CN101306072A Gadol buccal tablet and its preparation method
11/19/2008CN101306030A Compound breviscpini soft capsule and its preparation method
11/19/2008CN101306029A Hydroxypropyl¿Cbelta-cyclodextrin inclusion compound of Chinese angelica volatile oil, its preparation method and use
11/19/2008CN101306011A Function food for synthetically reducing blood pressure
11/19/2008CN101305984A Medicaments solution
11/19/2008CN101305798A Cailv capsules
11/19/2008CN101305777A Gingko pulp paste
11/19/2008CN100434422C Optical isomer of phencynonate and its use in preparing medicine
11/19/2008CN100434092C Prescription containing sweet clover component and its formulation
11/19/2008CN100434087C Compound oral prepn of muskone and total arasaponin and its application
11/19/2008CN100434081C Medicine for treating anal and bowel pile
11/19/2008CN100434071C Use of indole-2,3-dione for preparing medicine for cardio-cerehral vascular disease
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
11/18/2008US7452906 For therapy of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus
11/18/2008US7452891 MCH antagonists and their use in the treatment of obesity
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452884 Methods for inhibiting angiogenesis
11/18/2008US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
11/18/2008US7452875 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
11/18/2008CA2440222C Triazolopyridines as anti-inflammatory agents
11/18/2008CA2435613C An anti-atherosclerosis composition containing carotenoids and method for inhibiting ldl oxidation
11/18/2008CA2434682C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2415840C Pharmaceutical pellets comprising tamsulosin and a process for making the same
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2362281C Combinations for the treatment of diseases involving angiogenesis
11/18/2008CA2359640C Topical sprays
11/18/2008CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments
11/18/2008CA2318184C Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative as selective endothelin antagonists
11/18/2008CA2247115C Inhibition of selectin binding
11/18/2008CA2230516C Pyrimidine derivatives
11/18/2008CA2143752C Method of preventing nmda receptor-mediated neuronal damage
11/18/2008CA2124161C Pharmaceuticals for treating sepsis and septic shock
11/18/2008CA1341585C Recombinant retroviruses
11/13/2008WO2008137787A2 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008WO2008137778A2 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
11/13/2008WO2008137148A2 Methods and compositions for treating pulmonary hypertension
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008136756A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008WO2008136457A1 Nitrogen-containing aromatic derivative
11/13/2008WO2008136444A1 Fused heterocyclic derivative
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008136059A1 Composition for improving vascular endothelial function
11/13/2008WO2008136037A2 Chemical-catalytic method for the peracylation of oleuropein and its products of hydrolysis
11/13/2008WO2008135984A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level
11/13/2008WO2008135795A2 Polymorphic forms of bosentan
11/13/2008WO2008135661A2 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008WO2008135448A1 Beta-keto-amide derivatives useful as ion channel modulators
11/13/2008WO2008135447A1 Acetamide derivatives as potassium channel modulators
11/13/2008WO2008118454A3 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
11/13/2008WO2008115098A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
11/13/2008WO2008099186A8 Heterocyclic derivatives as m3 muscarinic receptors
11/13/2008WO2008097468A3 Selective endothelin type-a antagonists
11/13/2008WO2008083130A3 Amorphous and crystalline form a of carvedilol phosphate
11/13/2008WO2007145563A8 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
11/13/2008US20080281092 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
11/13/2008US20080280987 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
11/13/2008US20080280971 deuterated (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, used for the treatment of dyslipidemia and/or hyperlipemia
11/13/2008US20080280946 Azaindole-Derivatives As Factor Xa Inhibitors
11/13/2008US20080280939 Combination of Organic Compounds
11/13/2008US20080280932 Synergistic mixture of inosine monophosphate dehydrogenasr inhibitor and hydroxy-3-methylglutaryl coenzyme a reductase inhibitor; low dosage; transplant rejection therapy, atherosclerosis, cardiovascular disorders, lupus, irritable bowel disorders, Crohn'd disease, antidiabetic agents, rheumatic diseases
11/13/2008US20080280930 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors such as tert-butyl 7-[4'-(4''-fluorophenyl)-6'-isopropyl-2'-oxo-3'-methyl-pyrimidin-5'-yl]-(3,5-)dihydroxyl-hept-6-enoate, useful for preventing and treating alzheimer's disease, diabetes, osteoporosis, tumors, cardiovascular and brain disorders
11/13/2008US20080280927 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
11/13/2008US20080280920 Plasminogen Activator Inhibitor-1 Inhibitors
11/13/2008US20080280914 Intravenous Formulations of Pde Inhibitors
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280906 Imidazolyl-Pyrimidine Compounds for Use in the Treatment of Proliferative Disorders
11/13/2008US20080280905 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
11/13/2008US20080280898 5-Bromo-1'-[(3-methyl-1H-inden-2-yl)carbonyl]spiro[indole-3,4'-piperidin]-2(1H); vasopressin receptor antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
11/13/2008US20080280895 5-Amino-4-Hydroxy-7-(1H-Indolmethyl)-8-Methylnonamide Derivatives as Renin Inhibitors for the Treatment of Hypertension
11/13/2008US20080280886 Substituted ureas
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods
11/13/2008US20080280837 Biologically Active Compounds with Anti-Angiogenic Properties
11/13/2008US20080280811 Carbonic Anhydrase-1 and 2 signal inhibitor; of Vascular Endothelial Growth Factor signal inhibitor; kallikrein, kinin pathway inhibitor; Complement-1 Inhibitor agonist; injection into vitreous or aqueous humor of the eye; candidates by tested for significant difference in level of protein, mRNA
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279965 Treatment Of Injury To The Brain By Inhibition Of Acid Sensing ION Channels
11/13/2008US20080279949 Such as paclitaxel and stabilizer
11/13/2008US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier
11/13/2008US20080279925 Method(s) of preventing, arresting, reversing and treatment of atherosclerosis
1 ... 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 ... 1595